Other studies have demonstrated higher expression levels of TREM2 mRNA in leukocytes of patients with AD than in controls, which were found to be associated with cognitive decline and hippocampal atrophy [80, 81]. This evidence concerns the gene TREM2 and Alzheimer disease.